Track Record of Identifying Rare Wealth Creators

Your blog category

April 8, 2026
Export Revenue Mix: horizontal bars show FY20 28, FY21 26, FY22 22, FY23 18, FY24 14, FY25 11 (green for FY25).

Export Revenue Mix

Titan Biotech earns ₹53.90 crore from overseas markets across 100+ countries — 34.5% of total revenue. With a 3:1 forex earned-to-used ratio and a net forex surplus of ₹35.75 crore, this small-cap has built genuine international competitive strength. A deep-dive case study.
Do you like it?0
Read more
April 8, 2026
Infographic showing Asset Turnover Ratio by fiscal year from FY20 to FY25; blue bars rise from 14 to 22, with FY25 bar in green (target).

Asset Turnover Ratio

Titan Biotech's Asset Turnover Ratio tells a powerful story: from 1.18x in FY2015 to a peak of 1.42x during COVID demand to 0.94x during the current capex phase. A deep-dive case study.
Do you like it?0
Read more
April 8, 2026
Blue horizontal bar chart of Interest Coverage Ratio by fiscal year FY20–FY25; FY25 is 11 (green bar), other values: FY20 28, FY21 26, FY22 22, FY23 18, FY24 14.

Interest Coverage Ratio: The Debt Safety Metric That Reveals Whether a Company Can Survive an Earnings Downturn — How Indian Investors Can Use ICR to Separate Fortress Businesses from Ticking Time Bombs

📅 Published April 08, 2026 (Wednesday) Why Most Indian Retail Investors Ignore the One Ratio That Could Save Them from Catastrophic Losses The Indian stock market […]
Do you like it?0
Read more
April 8, 2026
Hero section with the title 'Zero Promoter Pledging' and a green FY21–FY25 milestone timeline from Compliance to All boxes.

Zero Promoter Pledging

In the Indian stock market, there is one silent killer that has destroyed more retail investor wealth than any market crash, any earnings miss, or any […]
Do you like it?0
Read more
Prev page
12345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879
Next page
+91-8448836436